Chromosome alignment maintenance requires the MAP RECQL4, mutated in the Rothmund-Thomson syndrome.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
02 2019
Historique:
received: 01 07 2018
revised: 25 01 2019
accepted: 25 01 2019
entrez: 6 2 2019
pubmed: 6 2 2019
medline: 6 2 2019
Statut: epublish

Résumé

RecQ-like helicase 4 (RECQL4) is mutated in patients suffering from the Rothmund-Thomson syndrome, a genetic disease characterized by premature aging, skeletal malformations, and high cancer susceptibility. Known roles of RECQL4 in DNA replication and repair provide a possible explanation of chromosome instability observed in patient cells. Here, we demonstrate that RECQL4 is a microtubule-associated protein (MAP) localizing to the mitotic spindle. RECQL4 depletion in M-phase-arrested frog egg extracts does not affect spindle assembly per se, but interferes with maintaining chromosome alignment at the metaphase plate. Low doses of nocodazole depolymerize RECQL4-depleted spindles more easily, suggesting abnormal microtubule-kinetochore interaction. Surprisingly, inter-kinetochore distance of sister chromatids is larger in depleted extracts and patient fibroblasts. Consistent with a role to maintain stable chromosome alignment, RECQL4 down-regulation in HeLa cells causes chromosome misalignment and delays mitotic progression. Importantly, these chromosome alignment defects are independent from RECQL4's reported roles in DNA replication and damage repair. Our data elucidate a novel function of RECQL4 in mitosis, and defects in mitotic chromosome alignment might be a contributing factor for the Rothmund-Thomson syndrome.

Identifiants

pubmed: 30718377
pii: 2/1/e201800120
doi: 10.26508/lsa.201800120
pmc: PMC6362308
pii:
doi:

Substances chimiques

Chromatin 0
Codon, Nonsense 0
Microtubule-Associated Proteins 0
RECQL4 protein, human EC 3.6.1.-
RecQ Helicases EC 3.6.4.12

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2019 Yokoyama et al.

Références

Aging Cell. 2012 Jun;11(3):456-66
pubmed: 22296597
Aging Cell. 2010 Jun;9(3):358-71
pubmed: 20222902
Cell Cycle. 2015;14(6):827-37
pubmed: 25590964
Orphanet J Rare Dis. 2010 Jan 29;5:2
pubmed: 20113479
J Biol Chem. 2012 Jan 2;287(1):196-209
pubmed: 22039056
Am J Med Genet A. 2003 Jul 30;120A(3):395-9
pubmed: 12838562
Oncogenesis. 2018 Sep 12;7(9):68
pubmed: 30206236
Gene. 2007 Apr 15;391(1-2):26-38
pubmed: 17250975
Nat Commun. 2014;5:3270
pubmed: 24509916
J Cell Biol. 2009 Dec 14;187(6):813-29
pubmed: 20008562
J Cell Biol. 2016 Dec 5;215(5):631-647
pubmed: 27881713
Front Oncol. 2013 Dec 16;3:308
pubmed: 24380075
J Cell Sci. 2012 May 15;125(Pt 10):2509-22
pubmed: 22357944
Hum Mol Genet. 2004 Oct 15;13(20):2421-30
pubmed: 15317757
Biology (Basel). 2017 Feb 17;6(1):
pubmed: 28218637
Exp Cell Res. 2006 Oct 15;312(17):3443-57
pubmed: 16949575
Nat Methods. 2010 Sep;7(9):747-54
pubmed: 20693996
Am J Hum Genet. 2002 Jul;71(1):165-7
pubmed: 12016592
Trends Cell Biol. 2016 Mar;26(3):161-164
pubmed: 26786773
Nat Rev Genet. 2012 Jan 24;13(3):189-203
pubmed: 22269907
Cell. 2007 Sep 7;130(5):893-905
pubmed: 17803911
EMBO J. 2009 Mar 4;28(5):568-77
pubmed: 19177149
Annu Rev Biochem. 2014;83:519-52
pubmed: 24606147
Semin Cell Dev Biol. 2011 Oct;22(8):906-12
pubmed: 21782962
Hum Mol Genet. 2003 Nov 1;12(21):2837-44
pubmed: 12952869
Dev Cell. 2014 Nov 10;31(3):305-318
pubmed: 25443297
Nat Protoc. 2006;1(5):2305-14
pubmed: 17406472
Cell Rep. 2016 Jun 28;16(1):161-173
pubmed: 27320928
Front Cell Dev Biol. 2016 Jan 11;3:82
pubmed: 26793706
Cell. 2001 Jan 12;104(1):83-93
pubmed: 11163242
Hum Mol Genet. 2005 Mar 15;14(6):813-25
pubmed: 15703196
Eur J Hum Genet. 2009 Feb;17(2):151-8
pubmed: 18716613
Methods Cell Biol. 2014;122:193-218
pubmed: 24857731
Trends Genet. 2012 Dec;28(12):624-31
pubmed: 22940096
Nature. 1999 Jul 8;400(6740):178-81
pubmed: 10408446
Nature. 1996 Aug 1;382(6590):420-5
pubmed: 8684481
Int J Cancer. 1998 Aug 12;77(4):504-10
pubmed: 9679749
Nihon Yakurigaku Zasshi. 2002 Apr;119(4):219-26
pubmed: 11979727
J Cell Sci. 2005 Sep 15;118(Pt 18):4261-9
pubmed: 16141230
Curr Biol. 2013 Dec 16;23(24):2443-51
pubmed: 24268414
J Cell Biol. 2013 Jul 8;202(1):81-95
pubmed: 23816619
DNA Repair (Amst). 2010 Jul 1;9(7):796-804
pubmed: 20451470
EMBO J. 2007 Mar 21;26(6):1487-98
pubmed: 17318179
Nat Genet. 1999 May;22(1):82-4
pubmed: 10319867
Sci Rep. 2017 Aug 30;7(1):9996
pubmed: 28855639
Cell. 2005 Jun 17;121(6):887-98
pubmed: 15960976
Curr Biol. 2015 Jun 1;25(11):1509-14
pubmed: 25981788
Mol Cell Biol. 2006 Jul;26(13):4843-52
pubmed: 16782873
Biochim Biophys Acta. 2007 Apr;1773(4):556-64
pubmed: 17320201
Curr Biol. 2010 Mar 23;20(6):R285-95
pubmed: 20334839
J Med Genet. 2006 Feb;43(2):148-52
pubmed: 15964893
Hum Mol Genet. 2003 Sep 15;12(18):2293-9
pubmed: 12915449
EMBO Rep. 2016 Mar;17(3):317-25
pubmed: 26882550

Auteurs

Hideki Yokoyama (H)

Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany hideki-yokoyama@idpharma.jp.
Institute of Biochemistry and Molecular Cell Biology, Medical School, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.
ID Pharma Co. Ltd., Tsukuba, Japan.

Daniel Moreno-Andres (D)

Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany.
Institute of Biochemistry and Molecular Cell Biology, Medical School, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.

Susanne A Astrinidis (SA)

Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany.

Yuqing Hao (Y)

Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Deutsches Krebsforschungszentrum-ZMBH Alliance, Heidelberg, Germany.

Marion Weberruss (M)

Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany.
Institute of Biochemistry and Molecular Cell Biology, Medical School, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.

Anna K Schellhaus (AK)

Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany.
Institute of Biochemistry and Molecular Cell Biology, Medical School, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.

Hongqi Lue (H)

Institute of Biochemistry and Molecular Cell Biology, Medical School, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.

Yoshikazu Haramoto (Y)

Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan.

Oliver J Gruss (OJ)

Institute of Genetics, Rheinische Friedrich-Wilhelms Universität Bonn, Bonn, Germany.

Wolfram Antonin (W)

Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany wantonin@ukaachen.de.
Institute of Biochemistry and Molecular Cell Biology, Medical School, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH